(Q37641309)

English

Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs

scientific article published on December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

author name string

Jordi Castellsague

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Crystal N Holick

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Clorinda C Hoffman

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Victoria Gimeno

4

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Mary-Rose Stang

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Susana Perez-Gutthann

6

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

language of work or name

0 references

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1397-1407

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Rules and laws of drug hepatotoxicity

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.12.1397

21 January 2018

Identifiers

10.1592/PHCO.29.12.1397

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37641309&oldid=2115327919"